Key Findings
- A 2025 meta-analysis of RCTs found probiotics were associated with reduced anxiety symptoms (SMD −0.44; 95% CI −0.59 to −0.28; anxiety analysis of 2,124 probiotic and 1,788 control participants) and reduced depression symptoms (SMD −0.53).
- An earlier 2019 meta-analysis (34 controlled trials) found smaller but significant probiotic effects (depression d≈−0.24), with larger effects in clinically diagnosed samples.
- Effect estimates therefore range from small to moderate across analyses, and both reviews flagged substantial heterogeneity between trials.
- Many trials studied probiotics alongside standard care rather than as a standalone treatment.